1 / 37

Common Cents Investment Group

Common Cents Investment Group. Monday February 24 th Biotechnology & Trading the News. Agenda. Market Updates CCIG Leadership Elections BitCoin Update - Weiyi Trading the News - Lindsey Biotechnology - Max. Market Update. Investopedia Simulator Game. Will end March 31 st , 2014

chacha
Télécharger la présentation

Common Cents Investment Group

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Common Cents Investment Group Monday February 24th Biotechnology & Trading the News

  2. Agenda • Market Updates • CCIG Leadership Elections • BitCoin Update - Weiyi • Trading the News - Lindsey • Biotechnology - Max

  3. Market Update

  4. Investopedia Simulator Game • Will end March 31st, 2014 • Top 3 winners will receive book(s) on investing 2014 • U.S. Equity Markets +2% • Random Equity Picks +5%

  5. Leadership Elections • Apply for 2014-2015 school year • Applications due March 17th (right before Spring Break) • Great resume booster • Learn more about investing

  6. BitCoin Update WeiyiXie

  7. Old News on BitCoins • “Chase-ingBitcoin: Is JPM Preparing To Unveil Its Own Electronic Currency?”http://www.zerohedge.com/news/2013-12-10/chasing-bitcoin-jpm-preparing-unveil-its-own-electronic-currency • News: 7/11 Convenience Store in Mexico decided to accept BitCoin.  • (But some of us are still talking about whether bitcoin is ponzi ...)http://www.cryptocoinsnews.com/2014/02/01/bitcoin-accepted-7-eleven-mexico/ • Wall Street's first ever Bitcoin report (December 2013) from Bank of America Merrill Lynch • http://cryptome.org/2013/12/boa-bitcoin.pdf • About BitCoin Investment Funds, earning 700% within 2013 • http://finance.yahoo.com/news/secondmarket-ceo-wall-street-put-203000747.html • “Recession-Plagued Nation Demands New Bubble To Invest In” • http://www.theonion.com/articles/recessionplagued-nation-demands-new-bubble-to-inve,2486/

  8. Debates on Risks of BitCoin • What if the government doesn’t accept it? • Ideology: Do you trust the centralization / centralized government or not? • Risk on BitCoin: 51% attack • Risk on bitcoins: price variability

  9. Valuation of bitcoin

  10. Functions of BitCoin Three Directions: 1. Inflation protection 2. e-business (PayPal, Visa, MasterCard, American Express) 3. International money transfer (Western Union, MoneyGram, SWIFT, ACH) • Black Market? • Regulation?

  11. Trading on News Lindsey Kathmann

  12. Trading on the News • All is speculative • How much of a risk are you willing to take • Make money on people reacting to bad news • Better for short term trades • Buy before estimated positive earning: speculative increase • Buy after bad earnings: “Sick puppy” • Pay attention to: • Stocks near 52 week low • Potential Earnings • Up and coming industries/stocks

  13. Where to look

  14. Groupon (GRPN) • Went down 22% in 1 day • WHY?

  15. GRPN • Coupon business deteriorating, so focusing on physical goods • Reorganizing the business can hurt their profit for an extended period of time • Groupon experienced high growth in 2013 • Investors question whether reorganization of the business will be successful

  16. American Apparel (AAP)

  17. Honda (HMC) • News: Reported near 52 week low • Why? • Ford has become more competitive • Anti-Japanese sentiments in China • Why is it a good time to buy? • December 2013: able to grow its sales in China by 60% • Show acceptance of Honda globally • Honda was in the negative column for January • Only down 2% vs 7% industry average • CR-V had a 2.4% sales increase • Introduced an Accord in all electric and gas-electric hybrid model for 2015 • Priced at 91% book value

  18. Potentially Massive Moving Stocks this Week

  19. SandRidge Energy (SD) • SandRidgeEnergy, an Oklahoma-based oil and gas company. • Some disappointment over the past year • Paid to acquire land in the Gulf of Mexico • Determined there wasn't enough available in the region to continue drilling • SandRidgeis now focusing intensely on its operations in the mid-continent: Mississippi, Kansas, Oklahoma, and North Dakota • Many believe this is where the real organic growth can come from for the company • 2 Key Variables to make or break stock prices: • Underlying price of the commodities- SandRidge is selling: gas and oil • How well the company did in predicting is validated reserves

  20. Biotechnology & Pharmaceuticals Max Layman iShares Nasdaq Biotechnology [IBB]: 88%(1-yr)

  21. Characteristics • Huge advances in medical technology in recent years • Obama Care • High Risk – High Reward Industry • Few companies are profitable • 319 Biotech companies • 143 Pharmaceutical companies

  22. Size Matters • Small Companies • Make it or break it • Operate without profit • May issue shares to raise capital • Acquisition target • Big Companies • Not gaining FDA approval doesn’t destroy company

  23. 3 Investment Strategies • FDA approval • Trade in anticipation of drug approval • Possible Acquisition Targets • Invest in small company with proven drug • Fundamental Investment • Invest in large company with large portfolio of drugs

  24. Approval Process • Phase I • Test on humans • Determine if side effects are serious • Phase II • Effectiveness at predetermined doses • Phase III • Compared to existing drugs • Blind tests • Is it effective, safe, and better than current treatments?

  25. What Type of Drug is it? • Cancer? • Gastro-Intestinal? • Headaches? • Diabetes? • Heart Disease? • Ruconest for hereditary angioedema?

  26. FDA Drug Approval Decision Calendar • March 21st 2014 • Celgene (CELG) - Apremilast for psoriatic arthritis • April 15th 2014 • Mankind (MNKD) - Afrezza for Type 1 and 2 diabetes  • Glaxo Smith Kline (GSK) - Abiglutide for diabetes • May 5th 2014 • AstraZeneca (AZN) - Epanova for hypercholesterolemia

  27. Example 1 of Approval Approval

  28. Example 2 of Approval Approval Pre-Decision Run Up

  29. Approval Not Given No Approval Pre-Decision Run Up

  30. Oxygen Biotherapeutics [OXBT] • FDA granted fast track for Levosimendan • Drug reduces morbidity in patients who have undergone cardiac surgery • Already approved in 50 countries • Phase III trials start in June 2014 • Single successful trial needed for apporoval • Market Cap $65M

  31. Oxygen Biotherapeutics [OXBT]

  32. Acquisition Targets • Small Cap companies • Already have drug approval

  33. Acquisition Targets – Example 1 • Galena Biopharma [GALE] • FDA approved pain medicine • Partnership with Teva Pharmaceuticals • Pipeline of drugs

  34. Acquisition Targets – Example 2 • Zogenix [ZGNX] • FDA approved pain medicine

  35. Looking for Good Fundamentals • Return on Assets > 0 • Return on Equity > 0 • Return on Investment > 0 • Debt/Equity <1 • Operating Margin > 15% • Price/Earnings > 0 • Performance [ttm] > 0 Results CELG – JAZZ – PRGO – QCOR – UTHR

  36. Looking For Good Fundamentals

More Related